C
1.74
0.09 (5.45%)
| Penutupan Terdahulu | 1.65 |
| Buka | 1.67 |
| Jumlah Dagangan | 660,970 |
| Purata Dagangan (3B) | 2,161,588 |
| Modal Pasaran | 153,597,200 |
| Harga / Buku (P/B) | 4.35 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 12 Nov 2025 |
| EPS Cair (TTM) | -0.730 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 5.18% |
| Nisbah Semasa (MRQ) | 2.09 |
| Aliran Tunai Operasi (OCF TTM) | -31.11 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -31.63 M |
| Pulangan Atas Aset (ROA TTM) | -107.53% |
| Pulangan Atas Ekuiti (ROE TTM) | -161.93% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Cognition Therapeutics, Inc. | Menurun | Menurun |
AISkor Stockmoo
-0.4
| Konsensus Penganalisis | -0.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -4.5 |
| Purata Bergerak Teknikal | 1.5 |
| Osilator Teknikal | 2.0 |
| Purata | -0.38 |
|
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 0.81% |
| % Dimiliki oleh Institusi | 18.87% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Bios Capital Management, Lp | 30 Sep 2025 | 6,000,000 |
| Hilton Capital Management, Llc | 30 Sep 2025 | 581,150 |
| Graham Capital Management, L.P. | 30 Sep 2025 | 226,557 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 3.00 (HC Wainwright & Co., 72.41%) | Beli |
| 3.00 (B. Riley Securities, 72.41%) | Beli | |
| Median | 3.00 (72.41%) | |
| Purata | 3.00 (72.41%) | |
| Jumlah | 2 Beli | |
| Harga Purata @ Panggilan | 1.60 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| HC Wainwright & Co. | 04 Dec 2025 | 3.00 (72.41%) | Beli | 1.80 |
| 19 Nov 2025 | 3.00 (72.41%) | Beli | 1.39 | |
| B. Riley Securities | 21 Nov 2025 | 3.00 (72.41%) | Beli | 1.39 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |